Strategic Distribution Partners Lavie Bio already collaborates with Syngenta on a biological insecticide program, has distribution through WinField United Canada, and partnered with Ceres Global Ag to integrate its bio-inoculant into regenerative initiatives. Following the ICL acquisition, there is potential to tap into larger distribution networks and capital. Sales teams should target seed companies, crop-protection distributors, and regional cooperatives to carry Yalos and Lavie Bio’s future bio-inoculants, with co-branding or private-label opportunities where appropriate.

Growing Market Demand There is strong and accelerating demand for microbiome-based ag-biologicals and bio-stimulants, especially for row crops under abiotic stress. Lavie Bio’s focus aligns with sustainability-driven adoption by major producers, retailers, and regenerative farming programs. This creates opportunities to pitch to large-scale growers, irrigation districts, and government-funded programs seeking proven, field-ready microbiome products.

Manufacturing Advantage Lavie Bio is pursuing microfermentor technology to improve production economics, supported by the Israel Innovation Authority. This can enable lower cost of goods, faster scale, and potential contract manufacturing or tech licensing to larger players. Position Lavie Bio as a supplier that can meet both product needs and scalable manufacturing capacity for customers seeking reliable, cost-effective bio-based solutions.

Strategic Capital Access The acquisition by ICL signals access to additional capital, strategic resources, and a broader customer base to accelerate adoption of Lavie Bio’s products across major crop portfolios. Business development should engage with ICL and Evogene networks for co-sell, co-dev, or licensing partnerships, and explore cross-selling Lavie Bio’s pipeline through ICL’s global channels.

North America Expansion Lavie Bio already has North American exposure through Ceres Global Ag and WinField United Canada, suggesting readiness to scale in key markets. Proactively engage seed companies, grain producers, and regional distributors to expand Yalos seed treatment and bio-inoculants into row crops, cereals, and specialty crops, while aligning with regulatory and certification programs to accelerate market entry.